Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Mandatory Product Listing, FDA Not Looking For Gate To Open Or Close On Supplements

Jul 22 2022

• By Hannah Daniel

• Source: Shutterstock

Related Content

US FDA Allows Supplement Firms More Time To Submit NDI Notifications, And For It To Respond

May 19 2022

AHPA Sees Pre-Market Approval Behind Legislation Titled ‘Mandatory Listing’ For Supplements In US

May 03 2022

Welch Leads US FDA’s Dietary Supplement Office

Mar 11 2022

Senate FDA User Fee Bill’s Mandatory Supplement Listing Provision Unites Industry In Opposition

Jun 16 2022

Protection For NDIs Bigger Concern In US Than Giving More Time For Notifications, CRN Contends

Jun 15 2022

Additional Topics

United States FDA Dietary Supplements Regulation Compliance Ingredients Guidance Documents Enforcement Consumer Companies

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window